XXII Congresso Brasileiro de Oncologia Clínica

Dados do Trabalho


Título

Analysis of the efficacy of alopecia degrees after implementation of the use of capillary cooling by air circulation in patients undergoing chemotherapy

Introdução

The incidence of Cancer has been increasing and therefore a greater investment in new technologies. Today we have alternatives that promote the management of side effects caused by chemotherapy such as alopecia, which most affect self-esteem and quality of life of patients. The cooling of the scalp has been used by the world since 1970 to reduce the alopecia induced by some chemotherapeutics.

Objetivo

The available scalp cooling systems demonstrate variable results between efficacy and tolerance. Implanted in August 2018, it promotes cooling of the scalp by circulation of extremely cold air with a thermal cap with internal fins guaranteeing turbulent flow, in order to evaluate its effectiveness.

Método

In the present study 19 patients were followed up, the nursing team performed photographic records and assessments of alopecia according to WHO classification throughout the treatment, dividing them into subgroups according to the chemotherapy received.

Resultado

Of the 19 patients, 64% were submitted to cooling in all cycles, until the end of the chemotherapy. 20% abandoned the use claiming too much time with the cap, 16% lost the agreement migrating to the SUS. The result was positive in all patients, regardless of sex, age, previous exposure of hair to tinctures. In the subgroup 1 that used the doxorubicin + cyclophosphamide regimen (4 cycles), followed by 12 weeks with the use of paclitaxel, we observed the loss of the wires corresponding to 25% of the initial volume until the end of the second cycle, migrate to paclitaxel, resuming capillary growth, being classified as grade 1 minimum hair loss. In subgroup 2 with a multidrug regimen of carboplatin, paclitaxel and docetaxel, we maintained a moderate loss of grade 2 in all cycles, and in subgroup 3 with regimens that included irinotecan and carboplatin, we maintained all of them in grade 0 classification without hair loss.

Conclusão

The efficacy of the scalp cooling system to prevent alopecia did not vary with other factors other than the medication used, but adherence of patients to follow all post-use system guidelines such as not to warm the scalp, decrease the length

Palavras-chave

alopecia ; capillary cooling by air circulation; chemotherapy

Área

Oncologia - Enfermagem em oncologia clínica

Autores

CAMILA OLIVA ZANOTTO ALFIERI, VANESSA NATALIE FRANCISCO, JULIANA COUTINHO PEDROSO